ARWR
ARWR
US04280A1007
Arrowhead Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 829.448.000 3.551.000
23258.2%
Cost of Revenue -- --
--
Gross Profit -- --
--
731.102.000 604.631.000
20.9%
Operating Income 98.346.000 -601.080.000
116.4%
Pretax Income 51.533.000 -612.460.000
108.4%
Net Income Common Stockholders -1.631.000 -599.493.000
99.7%
-- --
--
-- --
--
ende